The Asia Pacific Single-use Filtration Assemblies Market would witness market growth of 18.3% CAGR during the forecast period (2022-2028).
Single-use assemblies have gained popularity throughout the global biopharmaceutical community. This expedites the manufacturing and medication development processes. The single-use filtration assembly market is expanding due to increased R&D spending by biopharmaceutical companies. In developed countries, there has been significant growth in the release of new medications. Because of the rising use of single-use filtration assemblies in development, testing, and research, scaling is anticipated to drive market expansion.
Life sciences companies are adamant about avoiding the pricey and time-consuming washing required when employing stainless steel. The faster growth of global biotech enterprises has created a growth environment where a novel, disposable technology becomes more significant. As the pharmaceutical business, suppliers, CDMOs, and producers fall behind on the payments for single-use components during the anticipated period, the market will expand more quickly.
Significant regional expansion is projected due to the high population density, increasing cancer occurrence, and a growing number of healthcare facilities. As a result of the various emerging players in the region, the production of biosimilars is expected to increase in countries like China and India. The region's high burden of healthcare spending is attributed to the region's geriatric population, which can increase revenue. Lack of medical infrastructure, particularly for cancer patients, and an increase in the number of cancer patients in this region are providing opportunities for private players to get involved, invest in government support, and provide patients with more medical services for their treatment. As a result, the government's continued efforts to expand the healthcare industry would support market expansion.
The China market dominated the Asia Pacific Single-use Filtration Assemblies Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $633.9 million by 2028. The Japan market is estimated to grow a CAGR of 17.6% during (2022 - 2028). Additionally, The India market would experience a CAGR of 19% during (2022 - 2028).
Based on Application, the market is segmented into Bioprocessing/Biopharmaceuticals, Pharmaceuticals Manufacturing and Laboratory Use. Based on Type, the market is segmented into Membrane Filtration, Depth Filtration, Centrifugation and Others. Based on Membrane Filtration Type, the market is segmented into Tangential Flow Filtration (TFF) and Others. Based on Product, the market is segmented into Filters, Membranes, Cassettes, Cartridges, Manifold, Syringes and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Single-use Filtration Assemblies Market is Projected to reach USD 8.1 Billion by 2028, at a CAGR of 17.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, Sartorius AG, Repligen Corporation, Merck Millipore (Merck Group), Danaher Corporation, Thermo Fisher Scientific, Inc., Meissner Filtration Products, Inc., Cellab CDMO, Medela AG, and DrM, Dr. Mueller AG.
By Application
By Type
By Product
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 